0001213900-24-004999.txt : 20240119
0001213900-24-004999.hdr.sgml : 20240119
20240119193938
ACCESSION NUMBER: 0001213900-24-004999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240118
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szot Matthew K
CENTRAL INDEX KEY: 0001401385
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41596
FILM NUMBER: 24546833
MAIL ADDRESS:
STREET 1: 802 NORTH DOUTY STREET
CITY: HANFORD
STATE: CA
ZIP: 93230
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cadrenal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001937993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880860746
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 822 A1A NORTH
STREET 2: SUITE 300
CITY: PONTE VEDRA
STATE: FL
ZIP: 32082
BUSINESS PHONE: 904-300-0701
MAIL ADDRESS:
STREET 1: 822 A1A NORTH
STREET 2: SUITE 300
CITY: PONTE VEDRA
STATE: FL
ZIP: 32082
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-18
0
0001937993
Cadrenal Therapeutics, Inc.
CVKD
0001401385
Szot Matthew K
C/O CADRENAL THERAPEUTICS, INC.
822 A1A NORTH, SUITE 306
PONTE VEDRA,
FL
32082
0
1
0
0
Chief Financial Officer
0
Stock Options
0.94
2024-01-18
4
A
0
250000
0
A
2034-01-17
Common Stock
250000
250000
D
These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.
/s/ Matthew K. Szot
2024-01-19